Qalitex Advises Brands on Amazon's Heightened Scrutiny of Unsubstantiated Structure/Function Claims

June 14, 2025 03:15 AM AEST | By EIN Presswire
 Qalitex Advises Brands on Amazon's Heightened Scrutiny of Unsubstantiated Structure/Function Claims
Image source: EIN Presswire
IRVINE, CA, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- Qalitex Laboratories, a provider of product testing and compliance services, has issued an industry advisory addressing Amazon's increasing enforcement against unsubstantiated structure/function claims made by dietary supplement and wellness brands.

As Amazon continues to align its policies with regulatory standards, brands are facing stricter compliance reviews targeting improper health benefit statements.

Understanding Structure/Function Claims in Dietary Supplements
Structure/function claims describe the role of a nutrient or ingredient in maintaining normal structure or function in the human body.

Under FDA guidelines, such claims are distinct from disease treatment or prevention statements, which require formal drug approval. Permitted structure/function claims might reference general support for immune health, digestion, or energy metabolism, provided they are truthful and not misleading.

However, claims that imply disease treatment, prevention, or cure—such as reducing risk of cancer, reversing arthritis, or treating depression—fall outside permitted boundaries. Brands must carefully distinguish between legally permissible claims and prohibited therapeutic statements.

Amazon’s Expanding Role in Enforcing Structure/Function Claim Compliance
As part of its compliance obligations, Amazon requires all sellers to ensure that product listings meet FDA and FTC regulations. The platform has invested in internal compliance teams and automated screening tools that regularly monitor listings for violations.

Amazon’s review processes now scrutinize both new and existing listings, flagging claims that may violate federal regulations or platform policies.

Sellers whose listings contain unsupported or misleading health claims may face immediate enforcement actions, including listing removals and account suspensions.

Common Types of Claims Now Triggering Amazon Enforcement
Among the claims most frequently cited in Amazon compliance actions are:

Statements suggesting prevention, treatment, or cure of diseases.
Language implying therapeutic outcomes without clinical substantiation.
Vague or exaggerated health benefits that overstate product effects.
Use of unapproved medical terms in product titles, bullet points, or marketing descriptions.

Regulatory Background Driving Amazon’s Stricter Enforcement
The FDA has maintained long-standing rules prohibiting disease claims on dietary supplements without approved drug applications. In parallel, the FTC enforces truth-in-advertising laws, requiring that any health-related claims be supported by competent and reliable scientific evidence.

Amazon’s policy updates reflect growing pressure to ensure platform-wide compliance with these federal regulations. Recent public attention on misinformation related to supplement marketing has further contributed to heightened scrutiny.

Potential Consequences for Brands Violating Amazon’s Claim Policies
Brands that fail to comply with Amazon’s policies face serious consequences. These may include:

Immediate removal or suppression of non-compliant product listings.
Temporary or permanent suspension of seller accounts.
Delays in reinstating listings until full documentation is provided.
Permanent account deactivation for repeat violations or failure to resolve compliance issues.

Documentation Amazon May Require to Substantiate Claims
In response to claim violations, Amazon may request extensive documentation to verify product statements. Required materials may include:

Scientific substantiation for all structure/function claims.
Certificates of Analysis verifying ingredient identity and potency.
Clinical study data, where applicable.
Third-party laboratory reports validating product composition and safety.

The Role of Qalitex in Assisting Brands with Compliance Preparation
Qalitex provides compliance support services that help brands prepare defensible product documentation in alignment with regulatory standards. This includes third-party laboratory testing, document preparation, and claim reviews.

By ensuring that structure/function claims are appropriately substantiated and presented, Qalitex assists brands in minimizing their exposure to Amazon compliance actions and regulatory inquiries. All services are conducted according to existing scientific and legal standards.

Recommendations for Brands to Minimize Risk
To maintain compliance and reduce enforcement risks, Qalitex advises brands to:

Carefully review all marketing claims against FDA structure/function guidelines.
Avoid language that suggests disease treatment or prevention.
Retain comprehensive scientific substantiation for all product statements.
Conduct routine audits of Amazon listings for ongoing compliance.
Seek guidance from qualified regulatory professionals when preparing product documentation.

Proactive Claim Management Is Now Critical for Amazon Sellers
As Amazon intensifies its review of product claims, dietary supplement and wellness brands must exercise heightened diligence in managing their listings. Unsubstantiated structure/function claims represent a growing compliance vulnerability that can lead to significant operational disruptions.

With this advisory, Qalitex reaffirms its commitment to helping brands navigate the evolving intersection of regulatory oversight and marketplace enforcement, while promoting compliant and science-based product marketing practices.

Nour Abochama
Qalitex Laboratories
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.